Results 121 to 130 of about 5,016 (173)
A case of lepromatous leprosy in Arizona, United States. [PDF]
JAAD Case RepRobbins KK +3 more
europepmc +1 more source
Immune-Mediated Glomerulonephritis as Type 2 Lepra Reaction Posttreatment of Lepromatous Leprosy: A Case Report. [PDF]
Indian J NephrolKantak D, Dsouza M.
europepmc +1 more source
Lepromatous Leprosy in an Immunosuppressed Patient Due to Renal Transplantation Associated with Glucose-6-Phosphate Dehydrogenase Deficiency: A Diagnostic and Therapeutic Challenge. [PDF]
Indian Dermatol Online JFernández-Vela J +2 more
europepmc +1 more source
Case Report: Borderline Lepromatous Leprosy Therapy Complicated by Type 1 Leprosy Reaction and Adverse Reactions with Dapsone and Clofazimine. [PDF]
Am J Trop Med HygMatono T, Suzuki S, Mori S, Ato M.
europepmc +1 more source
Lepromatous leprosy infection from Mycobacterium lepromatosis without known risk factors or exposures in the Upper Midwest United States. [PDF]
JAAD Case RepFleischmann HB +2 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Isoniazid in lepromatous leprosy
Transactions of the Royal Society of Tropical Medicine and Hygiene, 1954Abstract 1. (1) Isoniazid was given a 6-months trial in eight patients suffering from lepromatous leprosy, some of whom had responded very poorly to previous sulphone treatment. 2. (2) Some form of lepra reaction occurred in all cases, causing treatment to be temporarily interrupted in two instances and dosage to be limited in two others. 3.
W H, JOPLING, D S, RIDLEY
openaire +2 more sources
Experimental Lepromatous Leprosy
Nature, 1967Injection of Mycobacterium leprae has produced leprosy in mice previously thymectomized and given 900 r. of whole body irradiation to depress their immunological capacity.
R J, Rees +3 more
openaire +2 more sources